SCHEMBL12674234

SCHEMBL12674234

B[C@@H]1O[C@H](COC)C(OP(C)(=O)O)C1OCCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1642430 1.00 — —
SCHEMBL10005840 1.00 — —
SCHEMBL12243052 0.92 — —
SCHEMBL13998597 0.92 — —
SCHEMBL12173555 0.92 — —
SCHEMBL19768566 0.91 IGF2R (0.35) —
SCHEMBL10005842 0.90 — —
SCHEMBL1644129 0.90 — —
SCHEMBL19608817 0.90 — —
SCHEMBL13706079 0.89 TLR4 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170327524-A1 GALNAC PHOSPHORAMIDITES, NUCLEIC ACID CONJUGATES THEREOF AND THEIR USE HOFFMANN-LA ROCHE INC. 2017-11-16 — — US disclosed
US-20110118339-A1 CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF ALNYLAM PHARMACEUTICALS, INC. (US) 2011-05-19 — — US disclosed
Send feedback